发明申请
US20090149397A1 TREATMENT OF CANCER WITH COMBINATIONS OF TOPOISOMERASE INHIBITORS AND PARP INHIBITORS
审中-公开
用TOPOISOMERASE抑制剂和PARP抑制剂联合治疗癌症
- 专利标题: TREATMENT OF CANCER WITH COMBINATIONS OF TOPOISOMERASE INHIBITORS AND PARP INHIBITORS
- 专利标题(中): 用TOPOISOMERASE抑制剂和PARP抑制剂联合治疗癌症
-
申请号: US12329503申请日: 2008-12-05
-
公开(公告)号: US20090149397A1公开(公告)日: 2009-06-11
- 发明人: Valeria Ossovskaya , Charles Bradley , Barry Sherman
- 申请人: Valeria Ossovskaya , Charles Bradley , Barry Sherman
- 专利权人: BiPar Sciences
- 当前专利权人: BiPar Sciences
- 主分类号: A61K31/166
- IPC分类号: A61K31/166 ; A61P35/00 ; A61K31/7028 ; A61K31/4545 ; A61K31/4375 ; A61K31/37 ; A61K31/496 ; A61K31/437 ; A61K31/195
摘要:
In one aspect, the present invention provides a composition and a kit comprising a combination of topoisomerase inhibitor and PARP inhibitor for treatment of cancer. In another aspect, the invention provides a method of treating cancer comprising administering to a subject a combination of topoisomerase inhibitor and PARP inhibitor. In particular, the invention provides compositions and methods for treating cancer in a subject by inhibiting a poly-ADP-ribose polymerase and a topoisomerase, as well as providing formulations and modes of administering such compositions.
信息查询